AR027738A1 - Composicion coadyuvante, composiciones de vacunas que incluyen dicha composicion coadyuvante; procedimiento de induccion de inmunorespuestas antigenicas enmamiferos y procedimiento de tratamiento donde se aplican dichas vacunas - Google Patents
Composicion coadyuvante, composiciones de vacunas que incluyen dicha composicion coadyuvante; procedimiento de induccion de inmunorespuestas antigenicas enmamiferos y procedimiento de tratamiento donde se aplican dichas vacunasInfo
- Publication number
- AR027738A1 AR027738A1 ARP010101488A ARP010101488A AR027738A1 AR 027738 A1 AR027738 A1 AR 027738A1 AR P010101488 A ARP010101488 A AR P010101488A AR P010101488 A ARP010101488 A AR P010101488A AR 027738 A1 AR027738 A1 AR 027738A1
- Authority
- AR
- Argentina
- Prior art keywords
- vaccines
- coadyuvante
- procedure
- composition
- compositions
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 6
- 239000000203 mixture Substances 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 3
- 230000006698 induction Effects 0.000 title 1
- 239000002671 adjuvant Substances 0.000 abstract 4
- 241000607734 Yersinia <bacteria> Species 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Composiciones coadyuvantes que son adecuadas para utilizarse en vacunas. En particular, las composiciones coadyuvantes de la presente invencion comprendenuna proteína de adhesion de Yersinia, opcionalmente con un portador. Se proporcionan también en la presente invencion vacunas que comprenden los coadyuvantesde la presente invencion y un antígeno. Se proporcionan además procedimientos de fabricacion de los coadyuvantes y vacunas de la presente invencion y su usocomo medicamentos. Se proporciona n también procedimientos de tratamiento de un individuo susceptible de, o que padece una enfermedad mediante la administracionde las vacunas de la presente invencion.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0025058.9A GB0025058D0 (en) | 2000-10-12 | 2000-10-12 | Composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR027738A1 true AR027738A1 (es) | 2003-04-09 |
Family
ID=9901176
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP010101488A AR027738A1 (es) | 2000-10-12 | 2001-03-28 | Composicion coadyuvante, composiciones de vacunas que incluyen dicha composicion coadyuvante; procedimiento de induccion de inmunorespuestas antigenicas enmamiferos y procedimiento de tratamiento donde se aplican dichas vacunas |
Country Status (5)
| Country | Link |
|---|---|
| AR (1) | AR027738A1 (es) |
| AU (1) | AU2001262163A1 (es) |
| CO (1) | CO5270014A1 (es) |
| GB (1) | GB0025058D0 (es) |
| WO (1) | WO2002030458A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2854803B1 (fr) * | 2003-05-16 | 2005-06-24 | Aventis Pasteur | Composition vaccinale comprenant du phosphate de fer a titre d'adjuvent vaccinal. |
| US20080226729A1 (en) * | 2006-09-08 | 2008-09-18 | Becton, Dickinson And Company | Stable powder formulations of alum-adsorbed vaccines |
| EP2034022A1 (en) | 2007-09-10 | 2009-03-11 | Universite Libre De Bruxelles | Leukotriene B4 binding soluble lipocalin receptor from ixodes ricinus |
| EP2045263A1 (en) | 2007-10-02 | 2009-04-08 | Universite Libre De Bruxelles | Identification and molecular characterisation of salivary metalloproteases expressed in the tick salivary glands |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5338842A (en) * | 1985-07-31 | 1994-08-16 | The Board Of Trustees Of Leland Stanford Jr. University | Yersinia INV nucleic acids |
| US5239066A (en) * | 1985-07-31 | 1993-08-24 | The Board Of Trustees Of Leland Stanford Jr. University | Yersinia ail nucleic acids |
| WO2000018355A2 (en) * | 1998-09-30 | 2000-04-06 | Walter Reed Army Institute Of Research | Use of purified invaplex from gram negative bacteria as a vaccine |
| EP1131338B1 (en) * | 1998-10-21 | 2005-03-02 | The University Of Kansas Center For Research, Inc. | Method for the production of purified invasin protein and use thereof |
-
2000
- 2000-10-12 GB GBGB0025058.9A patent/GB0025058D0/en not_active Ceased
-
2001
- 2001-03-26 WO PCT/EP2001/003786 patent/WO2002030458A1/en active Application Filing
- 2001-03-26 AU AU2001262163A patent/AU2001262163A1/en not_active Abandoned
- 2001-03-28 AR ARP010101488A patent/AR027738A1/es unknown
- 2001-03-30 CO CO01025486A patent/CO5270014A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2001262163A1 (en) | 2002-04-22 |
| WO2002030458A1 (en) | 2002-04-18 |
| GB0025058D0 (en) | 2000-11-29 |
| CO5270014A1 (es) | 2003-04-30 |
| WO2002030458A8 (en) | 2002-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20015073D0 (no) | Vaksiner | |
| BR0210628A (pt) | Liberação intradérmica de vacinas e agentes terapêuticos genéticos via microcânula | |
| CY1106602T1 (el) | Παραγωγα αδαμαντανιου για τη θεραπεια φλεγμονωδων, ανοσολογικων και καρδιαγγειακων ασθενειων | |
| MY129263A (en) | Vaccine composition | |
| HUP0101619A2 (hu) | Adjuvánskészítmények | |
| NO20031646L (no) | Adjuvanssammensetning omfattende et immunostimulatorisk oligonukleotid og en tokol | |
| ES2157447T3 (es) | Composicion de vacuna que comprende un antigeno de polisacarido conjugado adsorbido en fosfato de aluminio. | |
| TW200602077A (en) | Compositions as adjuvants to improve immune responses to vaccines and methods of use | |
| EP1385541A4 (en) | IMMUNOSTIMULANT COMPOSITIONS COMPRISING AMINOALKYL GLUCOSAMINIDE PHOSPHATE AND QS-21 | |
| GEP201706766B (en) | Methods and compositions for vaccinating against staphylococcus aureus | |
| ATE458496T1 (de) | Hiv-vakzine und anwendungsverfahren | |
| AR039982A1 (es) | Composicion vacunal contra las alergias, metodo para su obtencion y empleo en el tratamiento de las mismas | |
| AR027738A1 (es) | Composicion coadyuvante, composiciones de vacunas que incluyen dicha composicion coadyuvante; procedimiento de induccion de inmunorespuestas antigenicas enmamiferos y procedimiento de tratamiento donde se aplican dichas vacunas | |
| AR023536A1 (es) | Vacunas | |
| BRPI0414073A (pt) | método para induzir uma resposta imune contra infecção por rotavìrus a partir de um sorotipo de rotavìrus, e, uso de uma cepa de rotavìrus atenuado de um sorotipo | |
| ATE444762T1 (de) | Therapeutische zusammenseztungen zur toleranzinduktion | |
| ATE353226T1 (de) | Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form | |
| AR046921A1 (es) | Metodo para la incorporacion de antigenos en vesiculas de membrana externa de bacterias y formulaciones resultantes | |
| WO2004098636A3 (en) | Vaccinating against infectious diseases using proteosomes | |
| DE60233819D1 (de) | Doppelester | |
| FR2856598A1 (fr) | Peptides derives de la proteine mmp-2 et leur utilisation en immunotherapie antitumorale | |
| DK1237571T3 (da) | Toscana-virus-nukleinprotein | |
| UA38352A (uk) | Засіб для лікувальних ванн |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |